Bioelectronics Corporation
BIEL
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.88M
Close$
Share Statistics
| Market cap | $9.88 Million |
|---|---|
| Enterprise Value | $24.35 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 2.02 |
| Outstanding Shares | 24,705,066,971 |
Return
| Return on Equity | 6.12% |
|---|---|
| Return on Assets | -573.48% |
| Return on Invested Capital | 19.89% |
Valuation & Multiples
| P/E Ratio | -18.56 |
|---|---|
| PEG | -1.66 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 48.21 |
| Enterprise Value to EBIT | -35.6 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0.59 |
| Debt to Equity | -0.91 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bioelectronics Corporation
9 employees
CEO: Kelly A. Whelan BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a m...